Biosensors have a need to accurately detect and quantify a biological target within a complex medium, such as serum. Cells are uniquely qualified to accomplish this, but cannot communicate with the outside world. We demonstrate a synergistic fusion between a genetically engineered cell line and a wireless-compatible CMOS sensor leveraging the cells innate ability to specifically bind, amplify and transduce the signal with electronics that are capable transforming this cellular signal into an electronic one. We demonstrate the detection of TNFalpha (TNFα) within serum without washing. Since cells are real-time transducers of binding events, real-time monitoring of biological agents and reactions are possible.
INTRODUCTION
Current methods of biological detection rely on binding of the target to highly specific molecules, such as antibodies. This binding event is then transduced through a variety of methods, typically utilizing a labeled secondary antibody. Advances in microelectronic and MEMS-based approaches have leveraged this principle by using charge-based and magnetic-based approaches [1] , allowing a direct interface to the sensor. In a clinical setting, the target is contained in a biologically complex fluid, such as serum. This necessitates removing the unbound sample, and multiple wash steps to prevent nonspecific binding of the secondary antibody. These requirements necessitate labor intensive washing steps requiring trained technicians, limiting use to centralized facilities or requiring implementation of complex microfluidics.
Furthermore washing off the sample prevents real-time monitoring of the sample.
BACKGROUND
In living biological systems, specific ligand detection within a complex medium is continually necessary, but complex washing steps cannot be performed. Cells accomplish this by having highlyspecific receptors, as well as internal "signal processing" allowing thresholding and amplification of the binding event. We leverage these properties by using cells to detect the ligand, and have them communicate with a microfabricated sensor. Optically sensitive biological proteins have been widely used in biology, and span two main categories: fluorescent (i.e. GFP) and luminescent (i.e. luciferase). These have the advantage of being able to be genetically encoded into the cells DNA, and can signal a cellular event when they are synthesized. We use firefly luciferase, as the luminescent properties only require a substrate (luciferin, ATP and magnesium), and has no background.
The difficulty with using luciferase is the extremely low-light levels produced. Although PMTs (photomultiplier tubes) and CCDs (charge coupled devices) have traditionally been employed in the detection of luciferase, Complementary Metal Oxide Semiconductor (CMOS)-based platforms enable versatility, making them ideal for implementing a biosensor. In the case of a cellbased sensor, by integrating the cells directly on (or extremely close to) the sensor, light-gathering optics can be eliminated, reducing both the size and cost of the sensor. Additionally, the use of luminescence, as opposed to fluorescence, obviates the need for optical filters. Both of these techniques enable the sensor itself to be limited only by the size of the CMOS device. This results in a biosensor that can be fabricated at a size appropriate for integration into a biological or in-vivo environment.
In order to fully integrate the sensor with the cell, the sensor must be compatible with a fluidic, biological, or in-vivo environment. These requirements necessitate a wireless-compatible optical sensor, capable of receiving power and transmitting data wirelessly, while detecting extremely low amounts of light. CMOS provides the optimal platform, due to its ability to integrate optical sensors directly with electronics. Although CMOS sensors have been previously developed to sense luciferase [3, 4] , no wireless array-based imager exists that is fabricated in standard CMOS process. Here we use a sensor platform developed in our laboratory [2] (Figure 1 ) to monitor the detection of a ligand by cells genetically engineered to express luciferase upon receptor binding.
SENSOR DESCRIPTION
The sensor is a CMOS-based 64 pixel imager fabricated in a standard 0.18 µm digital process, powered by a single-sinusoidal power supply, and capable of transmitting data wirelessly enabling wireless- compatibility. Wireless power transfer can be achieved by bonding an external inductor to the imager. The primary difficulty with CMOS-based imagers for low-intensity imaging is the large dark current, typically 3 to 4 orders of magnitude larger than the luminescent signal. The circuit overcomes this limitation by having a fully differential design, with each 125 µm x 125 µm photodiode having an identical reference photodiode covered with metal. Ideally, the dark currents would precisely cancel each other, but mismatch between photodiodes results in a differential dark current. Since this current is constant, it is used to calibrate the chip, and can be subtracted from output. The output of each pixel is then amplified and converted to a digital representation by on-chip signal processing electronics. The results can either be wirelessly transmitted off-chip using an on-chip inductor made of several metal layers, or via standard bond-wires.
Figure 1: (a) Die photo of the 4 x 4 mm chip with 64 pixels. The layout of the chip is shown to the right. (b)Schematic of circuit operation. Each of the 64 pixels is sequentially read out by the on-chip amplifier and converted into a digital representation by a single slope analog to digital converter. The data can be output via standard IO pads, or wirelessly transmitted using the on-chip inductor. The chip is powered by a single sinusoidal power supply, making wireless operation possible with the addition of an external inductor.
We use HEK 293T cells genetically engineered to express firefly luciferase in response to TNF-α (Figure 2 
EXPERIMENTAL SETUP
To image the cells, the sensor is placed under a coverglass coated with cells, with one well incubated in TNFα plus serum, and the other a control well. The sensor can be moved to image either well (Figure 2b ). The cells are placed in an incubator with 5% CO2, and grown for variable amounts of time. Figure 3 shows the integrating trace for a single pixel imaging cells incubated in TNFα plus serum versus serum alone, for incubation times of 2 and 4 hours respectively. The integration trace with TNFα rises faster than the control trace (which is largely due to the differential dark current). After four hours, the control sample is unchanged, but the sample with TNFα shows increased luminescence. Figure 4 shows a plot of the integration time, as the sensor is moved from imaging the positive control to the negative control, and then back to the positive control. The lower integration times indicate a greater amount of light detected, corresponding to increased luciferase production. This experiment is repeated at multiple time points, shown in Figure 5 . As a reference, an identical set of cells are lysed, and the lysate is mixed with luciferase an imaged with a PMT-based luminometer. The results show a proportional increase in luciferase production with increased exposure time, with a maximal effect at approximately 800 minutes. This corresponds to the cells continuing to produce luciferase until the internal concentration reaches a steady state, balanced by protein destruction, cell division, and down-regulation of protein production.
RESULTS

DISCUSSION
These results show that genetically-engineered cells can be coupled with microelectronic devices to create sensors that can detect specific ligands within a complex mixture without the use of sample processing. This enables simplification of device design as well as the potential for real-time monitoring of ligand concentration. The cells have no background signal in the presence of serum, yet strongly express luciferase in the presence of TNFα demonstrating receptor activation. The expression as a function of time, corresponding to the real-time concentration of the ligand, can be monitored. Furthermore, the wireless interface enables compatibility with implantable applications where cells could be used to monitor physiologic, or pathological markers in real time. 
